Alira Health

Alira Health is a international advisory firm providing integrated n and innovation services for healthcare and life science companies. Our strategists, bankers, doctors and scientists collaborate to fully understand every aspect of healthcare.

Jean-Louis Simon

Partner

5 past transactions

CROS NT

Acquisition in 2021
CROS NT offers innovative, high-quality, tailored biometrics solutions. We support you in developing therapeutics for patients in a smarter manner by facilitating digital technologies, data integration, standardization, visualization and analytics, and data oversight.

X-COR Therapeutics

Seed Round in 2020
X-COR Therapeutics is a Boston based medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure. X-COR was the runner-up in the 2018 Harvard President’s Innovation Challenge with its device, a novel consumable hybrid cartridge that removes CO2 from patients’ blood with less invasive procedures than high-flow alternatives. X-COR is part of the 2018 MedTech Innovator and MassChallenge cohorts. X-COR’s core technology is a patent-pending medical device that allows physicians to remove excess CO2 from patients who are in symptomatic lung failure and its accompanying control algorithm that is based on machine-learning techniques. The system is compatible with existing medical device infrastructure for ease of use and deployment. Unlike other technologies to treat lung failure, X-COR uses a hybrid approach that allows patients’ blood to be drawn at <300 ml/min flows through small catheters that can be placed by nursing staff. This therapy is more affordable, safer, and more accessible than existing comparable extracorporeal devices that often require >3 L/min flows and highly specialized physicians.

Wellmera

Acquisition in 2019
Wellmera is a dynamic consulting firm combining market access, pricing, HEOR, and commercial expertise to help you demonstrate value, optimize patient access, and realize the commercial opportunity for your products.

Clinical Insights

Acquisition in 2018
Clinical Insights is provides tools and business advisory services based on rich data analytics for pharmaceutical companies. Its solutions optimizes performance using dynamic analytical techniques based on real-world and real-time market information; improves market insights and develop business solutions based on sophisticated analyses of big data available in real time; and improves business performance by embedding analytical techniques and real-time proprietary market information into the users management systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.